Showing 441 - 460 results of 1,890 for search '"Type 2 diabetes"', query time: 0.10s Refine Results
  1. 441

    Association of baseline and trajectory of triglyceride-glucose index with the incidence of cardiovascular autonomic neuropathy in type 2 diabetes mellitus by Qiong Huang, Wenbin Nan, Baimei He, Zhenhua Xing, Zhenyu Peng

    Published 2025-02-01
    “…However, the influence of baseline and prolonged TyG index patterns on CAN risk in type 2 diabetes remains unclear. Methods Based on the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, multivariate logistic regression models and restricted cubic splines (RCS) were deployed for elucidating the relation between baseline TyG index and the incidence of CAN. …”
    Get full text
    Article
  2. 442

    Thyroid disorders and the incidence of type 2 diabetes: insights from a 10-year cohort study in Germany by Theresia Sarabhai, Karel Kostev

    Published 2025-01-01
    “…Background: Thyroid dysfunctions, such as hypothyroidism and hyperthyroidism, are known to influence metabolism, but their long-term impact on the development of type 2 diabetes (T2D) mellitus in humans remains elusive. …”
    Get full text
    Article
  3. 443
  4. 444
  5. 445
  6. 446

    Effects of Sitagliptin Treatment on Dysmetabolism, Inflammation, and Oxidative Stress in an Animal Model of Type 2 Diabetes (ZDF Rat) by Liliana Ferreira, Edite Teixeira-de-Lemos, Filipa Pinto, Belmiro Parada, Cristina Mega, Helena Vala, Rui Pinto, Patrícia Garrido, José Sereno, Rosa Fernandes, Paulo Santos, Isabel Velada, Andreia Melo, Sara Nunes, Frederico Teixeira, Flávio Reis

    Published 2010-01-01
    “…The purpose of this paper is to evaluate the chronic effect of sitagliptin on metabolic profile, inflammation, and redox status in the Zucker Diabetic Fatty (ZDF) rat, an animal model of obese type 2 diabetes. Diabetic and obese ZDF (fa/fa) rats and their controls (ZDF +/+) were treated during 6 weeks with vehicle (control) and sitagliptin (10 mg/kg/bw). …”
    Get full text
    Article
  7. 447

    Triglyceride-glucose index is associated with microcirculatory resistance in patients with type 2 diabetes and STEMI undergoing primary PCI by Guoyu Wang, Cen Xu, Jian Wang, Zhimei Teng, Xiang Sha, Kai Xu, Ruzhu Wang, Li Zhu

    Published 2025-02-01
    “…However, the association between the TyG index and the AMR in patients with type 2 diabetes mellitus (T2DM) and ST-segment elevation myocardial infarction (STEMI) remains unclear. …”
    Get full text
    Article
  8. 448

    Serum Fibroblast Growth Factor 21 Levels Are Positively Associated with Metabolic Syndrome in Patients with Type 2 Diabetes by Ruo-Yao Gao, Bang-Gee Hsu, Du-An Wu, Jia-Sian Hou, Ming-Chun Chen

    Published 2019-01-01
    “…Serum FGF21 levels were significantly higher in obesity and type 2 diabetes mellitus (T2DM) populations. The aim of this study was to evaluate the relationship between serum FGF21 levels and metabolic syndrome (MetS) in T2DM patients. …”
    Get full text
    Article
  9. 449

    Age-Period-Cohort Analysis of Type 2 Diabetes Mortality Attributable to Particulate Matter Pollution in China and the U.S. by Xiaoxue Liu, Maigeng Zhou, Chuanhua Yu, Zhi-Jiang Zhang

    Published 2020-01-01
    “…We aimed to assess and compare secular trends in type 2 diabetes mortality attributable to particulate matter pollution in China and U.S. …”
    Get full text
    Article
  10. 450
  11. 451

    Relationship of Soluble RAGE with Insulin Resistance and Beta Cell Function during Development of Type 2 Diabetes Mellitus by Subrata Kumar Biswas, Sabreena Mohtarin, Sonchita Rani Mudi, Taznuva Anwar, Laila Anjuman Banu, Sheikh Md. Khorshed Alam, Md. Fariduddin, M. Iqbal Arslan

    Published 2015-01-01
    “…This study examined whether circulating levels of soluble receptor for advanced glycation end products (sRAGE) alter in prediabetes and correlate with insulin resistance (IR) and beta cell function in prediabetes and newly diagnosed type 2 diabetes mellitus (T2DM). Subjects without previous history of diabetes were recruited and grouped as control, prediabetes, and newly diagnosed T2DM. …”
    Get full text
    Article
  12. 452
  13. 453

    Effect of Long-Term Proton Pump Inhibitor Use on Glycemic Control in Patients with Type Two Diabetes Mellitus by Amy Trang, Jordan Bushman, Alexandra Halalau

    Published 2021-01-01
    “…There have been conflicting results regarding the effect of proton pump inhibitors (PPIs) as an adjunctive therapy to oral antidiabetic medication (OAM) in those with type 2 diabetes (T2DM). PPIs increase gastrin levels, causing a rise in insulin. …”
    Get full text
    Article
  14. 454

    Role of platelet indices and vitamin D in forecasting deterioration of glycemic control and vascular complications in type 2 diabetes by Maryam Ahmed Obaid Al Ali, Khalid Abdelsamea Mohamedahmed, Asaad Ma Babker

    Published 2025-01-01
    “… Type 2 diabetes mellitus (T2DM) is a prevalent chronic condition associated with various complications, including vascular ones. …”
    Get full text
    Article
  15. 455
  16. 456
  17. 457
  18. 458

    Effect of Sulodexide on Urinary Biomarkers of Kidney Injury in Normoalbuminuric Type 2 Diabetes: A Randomized Controlled Trial by Bancha Satirapoj, Wisit Kaewput, Ouppatham Supasyndh, Prajej Ruangkanchanasetr

    Published 2015-01-01
    “…In this 14-week trial, benefits of sulodexide in preventing the increase of urinary TGF-beta1 were observed in patients with normoalbuminuric type 2 diabetes. The study suggests that sulodexide treatment may provide additional renoprotection in early stage DN. …”
    Get full text
    Article
  19. 459

    Oral Findings, Salivary Copper, Magnesium, and Leptin in Type II Diabetic Patients in Relation to Oral Candida Species by Mohammed Jasim Mohammed, Abbas S. Al-mizraqchi, Salah M. Ibrahim

    Published 2024-01-01
    “…Background. Type 2 diabetes is a condition in which the body becomes resistant to the effects of insulin, leading to reduced insulin production in the pancreas. …”
    Get full text
    Article
  20. 460

    Prevalence of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in Iran: A Systematic Review and Meta-Analysis by Mohsen Kazeminia, Nader Salari, Masoud Mohammadi

    Published 2020-01-01
    “…Background. Type 2 diabetes mellitus (DM) is the most common type of DM and accounts for 90% of the cases. …”
    Get full text
    Article